Overview

Efficacy Study of Folinic Acid to Improve Mental Development of Children With Down Syndrome

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether folinic acid can improve developmental quotient of young Down syndrome patients, given that these present signs of folate deficiency which are known to cause reversible neurological, psychiatric and cognitive disorders.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Institut Jerome Lejeune
Collaborator:
Fondation Jérôme Lejeune
Treatments:
Folic Acid
Leucovorin
Levoleucovorin